Dual Antiplatelet Therapy vs Alteplase for Patients With Minor Nondisabling Acute Ischemic Stroke
Dawei Chen(General Hospital of Shenyang Military Region), Run-Hui Li(Central Hospital Affiliated to Shenyang Medical College), Hang Zhao, Lihong Zhang(Suizhou Central Hospital), Xinqiang Wang(Zhongyuan University of Technology), Li-Shu Wan, Er-Qiang Wang(Beijing Tian Tan Hospital), L. Xia, Yongzhong Lin(Dalian Medical University), Zhuo Gao(Jilin University), Duolao Wang(Guangdong Medical College), Guang-Bin Ma(Hainan Provincial Hospital of Traditional Chinese Medicine), Ruixian Wang(Tianjin Beichen Hospital), Thanh N. Nguyen(Cleveland Clinic), Xiaodong Liu(Shandong First Medical University), Shi-Mei Geng, Lian-Qiang Wang(Third People 's Hospital of Liaoyang), Yu Cui(Qingdao University), Jing Li(Longgang Central Hospital), Li Li(Henan Provincial People's Hospital), Jingyu Li(Ministry of Education of the People's Republic of China), Li Zhang(Fourth Hospital of Changsha), Xuewen Liu(Peking University), Zhuo Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Liying Shen, Ling Zhang(Suizhou Central Hospital), Yansong Li(University of Oslo), Yu-Ling Dong(Beijing Chaoyang Emergency Medical Center), Liyan Guo(Fuzhou Second Hospital), Hong Zhang(Guizhou University of Finance and Economics), Hulin Piao(Affiliated Zhongshan Hospital of Dalian University), Changhao Jiang(Dali Traditional Chinese Medicine Hospital), Qingcheng Yang(The Fifth People's Hospital of Anyang), Lixia Wang(Henan Provincial People's Hospital), Kui-Hua Yang(The Third People's Hospital of Dalian City), Jiang Lu, Jia-Dong Zhang, Zhonghe Zhou(Chinese Academy of Sciences), Jin Wang, Wenhai Yang(China Academy of Space Technology), Weizhong Wang(Xijing Hospital), Jing Han(Hebei Medical University), Shuman Huang(Beijing Tian Tan Hospital)
Cited by 209
Related Papers
China stroke surveillance report 2021
|Military Medical Research|2023|525
Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable <i>MET</i> Gene Mutations
|Journal of Clinical Oncology|2015|343
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
|Journal of Clinical Oncology|2022|334